LIBERVANT Trademark

Trademark Overview


On Friday, January 7, 2022, a trademark application was filed for LIBERVANT with the United States Patent and Trademark Office. The USPTO has given the LIBERVANT trademark a serial number of 97207918. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Friday, November 15, 2024. This trademark is owned by Aquestive Therapeutics, Inc.. The LIBERVANT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of neurological, cardiopulmonary, viral, metabolic, endocrine, musculoskeletal, genitourinary, gastrointestinal, oncological, autoimmune, inflammatory, pain, respiratory, hormonal, central nervous system, and psychiatric related diseases and disorders; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of epilepsy, anxiety disorders, seizure disorders, sleep disorders, insomnia, alcohol, opiate and benzodiazepine withdrawal syndrome, muscle spasms, and psychiatric disorders; pharmaceutical preparations, namely, anticonvulsants, anti seizure medications, psychotropics, benzodiazepines, sedatives, muscle relaxants, and mood stabilizing medications

General Information


Serial Number97207918
Word MarkLIBERVANT
Filing DateFriday, January 7, 2022
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateFriday, November 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 26, 2022

Trademark Statements


Description of MarkThe mark consists of the word "LIBERVANT" in blue font to the left of two overlapping triangles in the colors orange and yellow.
Goods and ServicesPharmaceutical preparations for the prevention and treatment of neurological, cardiopulmonary, viral, metabolic, endocrine, musculoskeletal, genitourinary, gastrointestinal, oncological, autoimmune, inflammatory, pain, respiratory, hormonal, central nervous system, and psychiatric related diseases and disorders; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of epilepsy, anxiety disorders, seizure disorders, sleep disorders, insomnia, alcohol, opiate and benzodiazepine withdrawal syndrome, muscle spasms, and psychiatric disorders; pharmaceutical preparations, namely, anticonvulsants, anti seizure medications, psychotropics, benzodiazepines, sedatives, muscle relaxants, and mood stabilizing medications
Indication of Colors claimedThe color(s) blue, orange and yellow is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 13, 2022
Primary Code005
First Use Anywhere DateMonday, April 29, 2024
First Use In Commerce DateMonday, April 29, 2024

Trademark Owner History


Party NameAquestive Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWarren, NJ 07059

Party NameAquestive Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWarren, NJ 07059

Trademark Events


Event DateEvent Description
Thursday, January 13, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 11, 2022NEW APPLICATION ENTERED
Friday, January 14, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, March 16, 2022ASSIGNED TO EXAMINER
Tuesday, March 22, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 26, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 25, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 25, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 25, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, August 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 28, 2022SOU TEAS EXTENSION RECEIVED
Monday, November 28, 2022SOU EXTENSION 1 FILED
Monday, November 28, 2022SOU EXTENSION 1 GRANTED
Wednesday, November 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 13, 2023ASSIGNED TO EXAMINER
Tuesday, May 30, 2023SOU EXTENSION 2 GRANTED
Tuesday, May 30, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 30, 2023SOU EXTENSION 2 FILED
Thursday, June 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 13, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 13, 2023SOU EXTENSION 3 FILED
Monday, November 13, 2023SOU EXTENSION 3 GRANTED
Wednesday, November 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 14, 2024SOU EXTENSION 4 FILED
Tuesday, May 14, 2024SOU EXTENSION 4 GRANTED
Tuesday, May 14, 2024SOU TEAS EXTENSION RECEIVED
Friday, July 26, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, May 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 26, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 26, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 26, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 13, 2024USE AMENDMENT FILED
Friday, September 13, 2024TEAS STATEMENT OF USE RECEIVED
Thursday, November 14, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 15, 2024STATEMENT OF USE PROCESSING COMPLETE